Tag Archives: Federal Circuit

Regents of the U. of Cal. v. Broad Inst. – “Just The Facts, Ma’am.”

The central theme in this interference decision involving U.S. Pat. No. 8,697,359 is the amount and type of evidence required to support the conception of an invention. Joe Friday wanted the witness to focus on the facts of the matter, … Continue reading

Posted in Federal Circuit, PTAB, Uncategorized | Tagged , | Leave a comment

Allergan v. Sun – A Glidant Slips Past the Written Description Requirement

The most interesting part of this decision by the Fed. Cir. (No. 24- 1061, Aug. 13, 2024) is that the court was faced with an argument by Sun that Allergan’s claims in U.S. Pat. No.11,311,516 et al. are invalid as … Continue reading

Posted in Litigation Issues, Uncategorized, Written Description Requirements (WDR) | Tagged , , , , | Leave a comment

Qualcomm v. Apple – Pyrrhic Victory for Qualcomm?

So far, it’s been a slow year for jurisprudence in the life sciences, so I thought I would take a look at the somewhat quirky decision in Qualcomm, Inc. v. Apple, Inc., Appeal nos. 2020-1558, -1559 (Fed. Cir., February 1, … Continue reading

Posted in Prior Art | Tagged , , | Leave a comment

Chemours Co. v. Daikin Industries – Back to Some IP Basics

After trying to untie the Gordian knot of patent eligibility, it is almost IP comfort food to read a Fed. Cir. decision that deals with obviousness. In Chemours Co. FC, LLC v Daikin Industries, Ltd., Appeal Nos. 2020-1289 and 2020-1290 … Continue reading

Posted in Obviousness | Tagged , | Leave a comment